Search by Drug Name or NDC

NDC 46708-0020-71 MEPROBAMATE 400 mg/1 Details

MEPROBAMATE 400 mg/1

MEPROBAMATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Limited. The primary component is MEPROBAMATE.

MedlinePlus Drug Summary

Meprobamate is used to treat anxiety disorders or for short-term relief of the symptoms of anxiety in adults and children 6 years of age and older. Meprobamate is in a class of medications called tranquilizers. It works by slowing activity in the brain to allow for relaxation.

Related Packages: 46708-0020-71
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Meprobamate

Product Information

NDC	46708-0020
Product ID	46708-020_8c5c7ad8-a128-4243-bd03-0e7057295b3f
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	MEPROBAMATE
Proprietary Name Suffix	n/a
Non-Proprietary Name	MEPROBAMATE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	400
Active Ingredient Units	mg/1
Substance Name	MEPROBAMATE
Labeler Name	Alembic Pharmaceuticals Limited
Pharmaceutical Class	n/a
DEA Schedule	CIV
Marketing Category	ANDA
Application Number	ANDA090122
Listing Certified Through	2024-12-31

Package

NDC 46708-0020-71 (46708002071)

Pricing Information	N/A
NDC Package Code	46708-020-71
Billing NDC	46708002071
Package	100 TABLET in 1 BOTTLE (46708-020-71)
Marketing Start Date	2013-07-23
NDC Exclude Flag	N